Allogeneic NK Cells
AB-101-05
Phase 2 small_molecule active
Quick answer
Allogeneic NK Cells for Refractory Rheumatoid Arthritis (RA) is a Phase 2 program (small_molecule) at Artiva Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Artiva Biotherapeutics
- Indication
- Refractory Rheumatoid Arthritis (RA)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active